48 related articles for article (PubMed ID: 24680928)
1. Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.
Wang X; Jiang F; Mu J; Ye X; Si L; Ning S; Li Z; Li Y
Toxicol Lett; 2014 Jun; 227(2):75-83. PubMed ID: 24680928
[TBL] [Abstract][Full Text] [Related]
2. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y
PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.
Dawood M; Hamdoun S; Efferth T
Front Pharmacol; 2018; 9():143. PubMed ID: 29535630
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of p53 Isoform Profiles and Apoptosis Induced by Camptothecin or a Herbal Khat Extract (
Onyango TB; Hjelle SM; Haaland I; Vintermyr OK; Johannessen AC; Gjertsen BT
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33271840
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma.
Zhu G; Li X; Li J; Zhou W; Chen Z; Fan Y; Jiang Y; Zhao Y; Sun G; Mao W
J Cancer; 2020; 11(22):6516-6529. PubMed ID: 33046973
[TBL] [Abstract][Full Text] [Related]
7. Combination of Arsenic Trioxide and Valproic Acid Efficiently Inhibits Growth of Lung Cancer Cells via G2/M-Phase Arrest and Apoptotic Cell Death.
Park HK; Han BR; Park WH
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290325
[TBL] [Abstract][Full Text] [Related]
8. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening.
Smith RA; Andrews KS; Brooks D; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC
CA Cancer J Clin; 2019 May; 69(3):184-210. PubMed ID: 30875085
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.
Toiyama Y; Okugawa Y; Fleshman J; Richard Boland C; Goel A
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):274-282. PubMed ID: 29852194
[TBL] [Abstract][Full Text] [Related]
10. MiR-370 promotes apoptosis in colon cancer by directly targeting MDM4.
Shen X; Zuo X; Zhang W; Bai Y; Qin X; Hou N
Oncol Lett; 2018 Feb; 15(2):1673-1679. PubMed ID: 29434862
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-Gene Interactions Impacted by Toxic Metal(oid)s during EMT and Carcinogenesis.
Tran F; Lee E; Cuddapah S; Choi BH; Dai W
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497298
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Alleviates 27-Hydroxycholesterol-Induced Senescence in Nerve Cells and Affects Zebrafish Locomotor Behavior via Activation of SIRT1-Mediated STAT3 Signaling.
Liu J; Jiao K; Zhou Q; Yang J; Yang K; Hu C; Zhou M; Li Z
Oxid Med Cell Longev; 2021; 2021():6673343. PubMed ID: 34239694
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3ε-mediated survival mechanism.
Jin M; Wu L; Chen S; Cai R; Dai Y; Yang H; Tang L; Li Y
Cell Death Discov; 2020; 6(1):92. PubMed ID: 33024577
[TBL] [Abstract][Full Text] [Related]
14. Serum Proteomic Profiling Analysis of Rats Chronically Exposed to Arsenic.
Zhang L; Huang J; Lin Q; Ma Y; Xia R; Zhu Y; Abudubari S
Med Sci Monit; 2019 Dec; 25():9923-9932. PubMed ID: 31874112
[TBL] [Abstract][Full Text] [Related]
15. Targeting E-cadherin expression with small molecules for digestive cancer treatment.
Song Y; Ye M; Zhou J; Wang Z; Zhu X
Am J Transl Res; 2019; 11(7):3932-3944. PubMed ID: 31396310
[TBL] [Abstract][Full Text] [Related]
16. Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α.
Qiu Y; Shan W; Yang Y; Jin M; Dai Y; Yang H; Jiao R; Xia Y; Liu Q; Ju L; Huang G; Zhang J; Yang L; Li L; Li Y
Cell Death Discov; 2019; 5():120. PubMed ID: 31341646
[TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment.
Ma Z; Fan Y; Wu Y; Kebebe D; Zhang B; Lu P; Pi J; Liu Z
Int J Nanomedicine; 2019; 14():2029-2053. PubMed ID: 30962686
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loop.
Qiu Y; Dai Y; Zhang C; Yang Y; Jin M; Shan W; Shen J; Lu M; Tang Z; Ju L; Wang Y; Jiao R; Xia Y; Huang G; Yang L; Li Y; Zhang J; Wong VKW; Jiang Z
J Exp Clin Cancer Res; 2018 Dec; 37(1):321. PubMed ID: 30572915
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up-regulation of TNF-related apoptosis-inducing ligand.
Wang L; Min Z; Wang X; Hu M; Song D; Ren Z; Cheng Y; Wang Y
Oncol Lett; 2018 Sep; 16(3):3341-3350. PubMed ID: 30127933
[TBL] [Abstract][Full Text] [Related]
20. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.
Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
